Zeytinburnu Community Mental Health Center (TRSM)
Istanbul, Turkey (Türkiye)
NCT Number: NCT07365982
This study aimed to examine the effect of a psychoeducation-based motivational interviewing intervention on schizophrenia-related knowledge and hope levels among patients diagnosed with schizophrenia. The study employed a randomized controlled experimental design with pre-test, post-test, and one-month follow-up measurements. Participants were recruited from a community mental health center and assigned to an intervention group or a control group. The intervention group participated in a structured psychoeducation-based motivational interviewing program consisting of one preparatory session followed by five main sessions, while the control group continued to receive routine community mental health services. Knowledge about schizophrenia and hope levels were assessed using validated measurement tools.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Istanbul, Turkey (Türkiye)
The present study aimed to examine the effect of a psychoeducation-based motivational interviewing intervention on schizophrenia-related knowledge and hope levels among patients diagnosed with schizophrenia. The study was conducted using a randomized controlled experimental design with pre-test, post-test, and one-month follow-up measurements.
A total of 44 patients diagnosed with schizophrenia were included in the study, with 21 participants assigned to the intervention group and 23 to the control group. The study was carried out with individuals followed at a community mental health center between January and June 2025.
Participants in the intervention group received a structured psychoeducation-based motivational interviewing program consisting of one preparatory session followed by five main sessions. The sessions were conducted at least once per week, and each session lasted approximately 60 to 90 minutes. Throughout the study period, the control group continued to receive routine community mental health services.
Data were collected using a Demographic Information Form, the Schizophrenia Knowledge Level Scale, and the Schizophrenia Hope Scale. Changes in knowledge and hope levels were evaluated across measurement points.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A structured psychoeducation-based motivational interviewing program delivered in weekly sessions lasting approximately 60-90 minutes, consisting of one preparatory session followed by five main sessions.
Time frame: Baseline (pre-test) prior to the intervention, immediately after completion of the final intervention session (post-test), and 1 month after completion of the intervention (follow-up assessment).
Change in schizophrenia-related knowledge level assessed using the Schizophrenia Knowledge Level Scale. The scale consists of multiple-choice items assessing knowledge about schizophrenia, with total scores ranging from 0 to 25. Higher scores indicate greater knowledge about schizophrenia.
Time frame: Baseline (pre-test) prior to the intervention, immediately after completion of the final intervention session (post-test), and 1 month after completion of the intervention (follow-up assessment).
Change in hope level assessed using the Schizophrenia Hope Scale. The scale is a Likert-type measure with total scores ranging from 0 to 18. Higher scores indicate higher levels of hope.
Büşra Taşkıner
Other
THE EFFECT OF PSYCHOEDUCATION-BASED MOTIVATIONAL INTERVIEWING ON KNOWLEDGE ABOUT SCHIZOPHRENIA AND HOPE LEVELS IN PATIENTS DIAGNOSED WITH SCHIZOPHRENIA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05838573
Cognition Disorders, Cognitive Dysfunction
Changsha, Hunan, China
View Trial DetailsNCT05304767
Mental Disorders, Schizophrenia
Phoenix, Arizona, United States
View Trial DetailsNCT00004571
Mental Disorders, Normal Physiology
Bethesda, Maryland, United States
View Trial DetailsNCT05808244
Mental Disorders, Psychosis
Kowloon, Hong Kong
View Trial Details